Stockreport

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

NeoGenomics, Inc.  (NEO) 
Last neogenomics, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.neogenomics.com
PDF FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will present three studies at the European Society fo [Read more]